BioNotebook: Five biotech deals; KaloBios,Sanofi 'divorce,' PaxVax/Crucell, Galena/MonoSol, Anacor/Sandoz, Celladon/Enterprise Partners
This article was originally published in Scrip
Executive Summary
Biotechnology companies often rely on a marriage of their science with a bigger company's experience to bring new therapies to patients; sometimes the collaborations end with a marketed drug and sometimes partners end their alliances early.